European Journal of Biomedical and Pharmaceutical Sciences

TRANSPLANT IMMUNOLOGY- AN OVERVIEW

Davuluri Ooha*, S. Sundar, Sravya K., Lakshmidevi Sigatapu, K. Aarika

ABSTRACT

The process of replacing a cell, organ, or tissue with a healthy counterpart is known as transplantation. Every year, hundreds of organs, tissues, and cells are transplanted throughout the world. Human immunological reactions to the graft are the main obstacle to the transplantation of organs, tissues, and cells. The transplant will be rejected if the recipient's immune system rejects it because it is foreign. Recipients of immunosuppressive medications have an increased risk of infection and cancer because the drugs non-specific immune system inhibition. Longer transplant longevity is promised by new techniques being developed to induce particular tolerance to the graft without dampening other host immune responses. More transplant recipients are put on a lifelong combination immunological medication or steroid therapy to prevent graft rejection. Despite its toxicity and side effects, this medication does not work to stop chronic graft rejection. Additionally, immune suppressive drugs non-specifically weaken the immune system, increasing the risk of infections and cancer in their users. Longer transplant longevity is promised by new techniques being developed to induce particular tolerance to the graft without dampening other host immune responses. To keep improving transplant immunology, immunosuppression will require ongoing critical approaches, review, and customization. Additionally, longer-term immunosuppression-related comorbidities, primarily chronic kidney disease (CKD) and cancer, have increased as a result of improved survival after lung transplantation, necessitating more sophisticated management strategies.

Keywords: Graft, Transplant, Donor, Recipient, Immune system, Hemopoietic system.